Omega Ophthalmics LLC is thrilled to announce the appointment of John W. Sheets, Jr., Ph.D., as its new Chief Operating Officer. This key hire comes at an exciting time as the company advances its innovative ophthalmic technologies through the FDA approval process.

John brings a wealth of expertise and leadership to Omega Ophthalmics, with a distinguished career spanning senior roles in top-tier companies and government agencies within the ophthalmology field. His experience includes serving as Senior Vice President of Corporate Research at Boston Scientific, Head of Global Research and CTO at Bausch + Lomb, Global President and CEO of HOYA Surgical, CTO of Johnson & Johnson’s ETHICON, Director of the FDA’s Office of Device Evaluation, and Vice President of Surgical Research & Development at Alcon.

With his proven track record of driving innovation and navigating regulatory landscapes, John is ideally positioned to lead Omega Ophthalmics’ operations and help bring groundbreaking eye care solutions to market. The company looks forward to the dynamic growth and success his leadership will inspire.

Welcome to the team, John — together we are shaping the future of ophthalmic care!